Acta Med. 2020, 63: 176-182

https://doi.org/10.14712/18059694.2020.60

Safety and Efficacy of Using Tranexamic Acid at the Beginning of Robotic-Assisted Radical Prostatectomy in a Double-Blind Prospective Randomized Pilot Study

Michal Balíka, Josef Košinaa, Petr Hušeka, Miloš Broďáka, Filip Čečkab

aDepartment of Urology, Faculty of Medicine and University Hospital Hradec Králové, Czech Republic
bDepartment of Surgery, Faculty of Medicine and University Hospital Hradec Králové, Czech Republic

Received May 24, 2020
Accepted September 29, 2020

References

1. Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 2014; 65(1): 124–37. <https://doi.org/10.1016/j.eururo.2013.09.046>
2. Mottet N, Bellmunt J, Bolla M, Briers E, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2017; 71(4): 618–29. <https://doi.org/10.1016/j.eururo.2016.08.003>
3. Nilsson S, Norlen BJ, Widmark A. A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 2004; 43(4): 316–81. <https://doi.org/10.1080/02841860410030661>
4. Barry MJ, Gallagher PM, Skinner JS, Fowler FJ, Jr. Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol 2012; 30(5): 513–8. <https://doi.org/10.1200/JCO.2011.36.8621> <PubMed>
5. Gandaglia G, Sammon JD, Chang SL, et al. Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol 2014; 32(14): 1419–26. <https://doi.org/10.1200/JCO.2013.53.5096>
6. Kasabwala K, Patel NA, Hu JC. Review of optimal techniques for robotic- assisted radical prostatectomy. Curr Opin Urol 2018; 28(2): 102–7. <https://doi.org/10.1097/MOU.0000000000000473>
7. Montorsi F, Wilson TG, Rosen RC, et al. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol 2012; 62(3): 368–81. <https://doi.org/10.1016/j.eururo.2012.05.057>
8. Sammon JD, Karakiewicz PI, Sun M, et al. Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol 2013; 189(4): 1289–94. <https://doi.org/10.1016/j.juro.2012.10.028>
9. Lee SJ, Seo H, Kim HC, et al. Effect of Intraoperative Red Blood Cell Transfusion on Postoperative Complications After Open Radical Cystectomy: Old Versus Fresh Stored Blood. Clin Genitourin Cancer 2015; 13(6): 581–7. <https://doi.org/10.1016/j.clgc.2015.06.002>
10. Linder BJ, Frank I, Cheville JC, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013; 63(5): 839–45. <https://doi.org/10.1016/j.eururo.2013.01.004>
11. Wang YL, Jiang B, Yin FF, et al. Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis. PLoS One 2015; 10(6): e0130122. <https://doi.org/10.1371/journal.pone.0130122> <PubMed>
12. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57(6): 1005–32. <https://doi.org/10.2165/00003495-199957060-00017>
13. Erstad BL. Systemic hemostatic medications for reducing surgical blood loss. Ann Pharmacother 2001; 35(7–8): 925–34. <https://doi.org/10.1345/aph.10337>
14. McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 2012; 72(5): 585–617. <https://doi.org/10.2165/11209070-000000000-00000>
15. Benoni G, Lethagen S, Nilsson P, Fredin H. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand 2000; 71(3): 250–4. <https://doi.org/10.1080/000164700317411834>
16. Nielsen JD, Gram J, Fabrin K, Holm-Nielsen A, Jespersen J. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate. Br J Urol 1997; 80(1): 105–10. <https://doi.org/10.1046/j.1464-410X.1997.00251.x>
17. Sharifi R, Lee M, Ray P, Millner SN, Dupont PF. Safety and efficacy of intravesical aminocaproic acid for bleeding after transurethral resection of prostate. Urology 1986; 27(3): 214–9. <https://doi.org/10.1016/0090-4295(86)90277-3>
18. Casati V, Guzzon D, Oppizzi M, et al. Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. Ann Thorac Surg 1999; 68(6): 2252–6; discussion 6–7. <https://doi.org/10.1016/S0003-4975(99)00866-8>
19. Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 2007; 107(4): 397–401. <https://doi.org/10.1080/00015458.2007.11680081>
20. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358(22): 2319–31. <https://doi.org/10.1056/NEJMoa0802395>
21. Jendoubi A, Malouch A, Bouzouita A, et al. [Safety and efficacy of intravenous tranexamic acid in endoscopic transurethral resections in urology: Prospective randomized trial]. Prog Urol 2017; 27(16): 1036–42. <https://doi.org/10.1016/j.purol.2017.09.008>
22. Kumsar S, Dirim A, Toksoz S, Saglam HS, Adsan O. Tranexamic acid decreases blood loss during transurethral resection of the prostate (TUR-P). Cent European J Urol 2011; 64(3): 156–8. <https://doi.org/10.5173/ceju.2011.03.art13> <PubMed>
23. Pourfakhr P, Gatavi E, Gooran S, et al. Local Administration of Tranexamic Acid During Prostatectomy Surgery: Effects on Reducing the Amount of Bleeding. Nephrourol Mon 2016; 8(6): e40409. <https://doi.org/10.5812/numonthly.40409> <PubMed>
24. Rannikko A, Petas A, Taari K. Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy. Urology 2004; 64(5): 955–8. <https://doi.org/10.1016/j.urology.2004.07.008>
25. Zaid HB, Yang DY, Tollefson MK, et al. Efficacy and Safety of Intraoperative Tranexamic Acid Infusion for Reducing Blood Transfusion During Open Radical Cystectomy. Urology 2016; 92: 57–62. <https://doi.org/10.1016/j.urology.2016.02.044>
26. Montroy J, Fergusson NA, Hutton B, et al. The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta- Analysis. Transfus Med Rev 2017; 31(3): 141–8. <https://doi.org/10.1016/j.tmrv.2017.03.002>
27. Breau RH, Kokolo MB, Punjani N, et al. The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis. Transfus Med Rev 2014; 28(3): 145–55. <https://doi.org/10.1016/j.tmrv.2014.05.002>
28. Wright JD, Ananth CV, Lewin SN, et al. Patterns of use of hemostatic agents in patients undergoing major surgery. J Surg Res 2014; 186(1): 458–66. <https://doi.org/10.1016/j.jss.2013.07.042> <PubMed>
29. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2): 205–13. <https://doi.org/10.1097/01.sla.0000133083.54934.ae> <PubMed>
30. Tikkinen KAO, Craigie S, Agarwal A, et al. Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis. Eur Urol 2018; 73(2): 242–51. <https://doi.org/10.1016/j.eururo.2017.03.008>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive